Ampio Pharmaceuticals Holds Groundbreaking Ceremony for Colorado Manufacturing Facility

Ampio Pharmaceuticals, Inc., a Denver-based biopharmaceutical company, recently broke ground on its new location in Englewood, Colo. On January 10, the company held a ceremony to announce the start of construction on its new facility, which will become the manufacturing site for their leading drug candidate.

GBA was honored to be selected by Ampio to design and construct a clean room,

laboratories, a warehouse and offices within the new facility. GBA’s Life Sciences team will also serve as the project and construction managers on the project.

The facility is expected to be up and running this summer, and will add approximately 40 new jobs to the Denver Metro area over the next two years. Once completed, the site will have an annual production capacity of approximately ten million doses of Ampion, an anti-inflammatory drug that treats patients with severe knee pain due to osteoarthritis. In addition to Ampion, Ampio also produces medications for kidney, eye and metabolic diseases, among others.